BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  C2C Services & Suppliers™
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile

 

Aton Pharma, Inc. (Acquired by Merck & Co., Inc.) 

Press releases archived for reference only.

Tarrytown  New York  10591-6717  U.S.A.
Phone: 914-347-2900 Fax: 914-347-2002


SEARCH JOBS










 Company News
Valeant Pharmaceuticals International (VRX) Completes Acquisition of Aton Pharma, Inc. 5/27/2010 8:46:32 AM
Aton Pharma, Inc.: Study of Lacrisert(R) Dry Eye Insert 5/3/2010 1:09:41 PM
Valeant Pharmaceuticals International (VRX) to Acquire Aton Pharma, Inc. for About $318 Million 5/3/2010 7:25:23 AM
Bristol-Myers Squibb Company (BMY) Parkinsons's Drug Acquired by Aton Pharma, Inc. 4/26/2010 8:34:29 AM
Aton Pharma, Inc. Launches Authorized Generic Version of Glaucoma Eye Drop Timoptic-XE(R) Gel Forming Solution 3/9/2010 10:51:44 AM
Aton Pharma, Inc. Appoints Dr. Wayne Mulcahy to Vice President, Clinical Operations 2/16/2010 9:03:09 AM
Aton Pharma, Inc. Announces Michael H. Richardson to Head Orphan Drug Division 2/9/2010 8:22:33 AM
Aton Pharma, Inc. Study of Lacrisert(R) Dry Eye Insert Published in The Ocular Surface 8/19/2009 8:41:43 AM
Aton Pharma, Inc. Release: Association for Research in Vision & Ophthalmology, AOS: Large Study of Lacrisert(R) Dry Eye Insert; Patients Experience Significant Improvement in Ocular Surface Disease and Quality of Life 5/4/2009 11:13:06 AM
Aton Pharma, Inc. Announces Large Study of Lacrisert(R) Dry Eye Insert 5/4/2009 8:13:57 AM
12